This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...